首页 > 最新文献

Journal of Skin Cancer最新文献

英文 中文
Melanocyte and melanoma cell activation by calprotectin. 钙保护蛋白激活黑素细胞和黑色素瘤细胞。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2014-01-01 Epub Date: 2014-08-12 DOI: 10.1155/2014/846249
Stephanie H Shirley, Kristine von Maltzan, Paige O Robbins, Donna F Kusewitt

Calprotectin, a heterodimer of S100A8 and S100A9, is a proinflammatory cytokine released from ultraviolet radiation-exposed keratinocytes. Calprotectin binds to Toll-like receptor 4, the receptor for advanced glycation end-products, and extracellular matrix metalloproteinase inducer on target cells to stimulate migration. Melanocytes and melanoma cells produce little if any calprotectin, but they do express receptors for the cytokine. Thus, keratinocyte-derived calprotectin has the potential to activate melanocytes and melanoma cells within the epidermis in a paracrine manner. We examined the ability of calprotectin to stimulate proliferation and migration in normal human melanocytes and melanoma cells in vitro. We first showed, by immunofluorescence and quantitative RT-PCR, that the melanocytic cells employed expressed a calprotectin receptor, the receptor for advanced end-products. We then demonstrated that calprotectin significantly enhanced proliferation, migration, and Matrigel invasion in both normal human melanocytes and melanoma cells. Thus, calprotectin is one of the numerous paracrine factors released by ultraviolet radiation-exposed keratinocytes that may promote melanomagenesis and is a potential target for melanoma prevention or therapy.

钙保护蛋白是S100A8和S100A9的异源二聚体,是紫外线照射下角质形成细胞释放的促炎细胞因子。钙保护蛋白结合toll样受体4(晚期糖基化终产物受体)和细胞外基质金属蛋白酶诱导剂在靶细胞上刺激迁移。黑素细胞和黑色素瘤细胞几乎不产生钙保护蛋白,但它们确实表达细胞因子的受体。因此,角化细胞衍生的钙保护蛋白具有以旁分泌方式激活表皮内的黑色素细胞和黑色素瘤细胞的潜力。我们检测了钙保护蛋白在体外刺激正常人类黑色素细胞和黑色素瘤细胞增殖和迁移的能力。我们首先通过免疫荧光和定量RT-PCR显示,使用的黑素细胞表达钙保护蛋白受体,这是晚期终产物的受体。然后,我们证明钙保护蛋白显著增强了正常人类黑色素细胞和黑色素瘤细胞的增殖、迁移和基质入侵。因此,钙保护蛋白是暴露在紫外线照射下的角质形成细胞释放的众多旁分泌因子之一,可能促进黑色素瘤的形成,是黑色素瘤预防或治疗的潜在靶点。
{"title":"Melanocyte and melanoma cell activation by calprotectin.","authors":"Stephanie H Shirley,&nbsp;Kristine von Maltzan,&nbsp;Paige O Robbins,&nbsp;Donna F Kusewitt","doi":"10.1155/2014/846249","DOIUrl":"https://doi.org/10.1155/2014/846249","url":null,"abstract":"<p><p>Calprotectin, a heterodimer of S100A8 and S100A9, is a proinflammatory cytokine released from ultraviolet radiation-exposed keratinocytes. Calprotectin binds to Toll-like receptor 4, the receptor for advanced glycation end-products, and extracellular matrix metalloproteinase inducer on target cells to stimulate migration. Melanocytes and melanoma cells produce little if any calprotectin, but they do express receptors for the cytokine. Thus, keratinocyte-derived calprotectin has the potential to activate melanocytes and melanoma cells within the epidermis in a paracrine manner. We examined the ability of calprotectin to stimulate proliferation and migration in normal human melanocytes and melanoma cells in vitro. We first showed, by immunofluorescence and quantitative RT-PCR, that the melanocytic cells employed expressed a calprotectin receptor, the receptor for advanced end-products. We then demonstrated that calprotectin significantly enhanced proliferation, migration, and Matrigel invasion in both normal human melanocytes and melanoma cells. Thus, calprotectin is one of the numerous paracrine factors released by ultraviolet radiation-exposed keratinocytes that may promote melanomagenesis and is a potential target for melanoma prevention or therapy. </p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2014 ","pages":"846249"},"PeriodicalIF":1.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/846249","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32648290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Decrease in Self-Reported Tanning Frequency among Utah Teens following the Passage of Utah Senate Bill 41: An Analysis of the Effects of Youth-Access Restriction Laws on Tanning Behaviors. 犹他州参议院第41号法案通过后,犹他州青少年自我报告的晒黑频率下降:青少年访问限制法律对晒黑行为的影响分析。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2014-01-01 Epub Date: 2014-08-20 DOI: 10.1155/2014/839601
Rebecca G Simmons, Kristi Smith, Meghan Balough, Michael Friedrichs

Introduction. Adolescent use of indoor tanning facilities is associated with an increased risk in later development of melanoma skin cancers. States that have imposed age restrictions on access to indoor tanning generally show lower self-reported rates of indoor tanning than states with no restrictions, but currently no studies have assessed indoor tanning use before and after such restrictions. Methods. In 2013, we compared self-reported indoor tanning data collected in the Prevention Needs Assessment (PNA) survey in 2011 to PNA 2013 data. We also assessed predictors of continued tanning after passage of the bill. Results. Prior to the passage of Senate Bill 41, 12% of students reported at least one incident of indoor tanning in the past 12 months. After passage, only 7% of students reported indoor tanning in the past 12 months (P < 0.0001). Students who continued indoor tanning were more likely to be older and female and to engage in other risk behaviors, including smoking and alcohol use. Lower parental education levels were also associated with continued tanning. Conclusion. Indoor tanning restrictions showed beneficial impact on tanning rates in adolescents in Utah. Stricter restrictions may show even greater impact than restrictions that allow for parental waivers. Stronger enforcement of bans is needed to further reduce youth access.

介绍。青少年使用室内晒黑设施与后期发展为黑色素瘤皮肤癌的风险增加有关。对进入室内美黑进行年龄限制的州通常比没有限制的州显示出更低的室内美黑自我报告率,但目前没有研究评估在这些限制之前和之后的室内美黑使用情况。方法。2013年,我们比较了2011年预防需求评估(PNA)调查中收集的自我报告的室内晒黑数据与2013年PNA数据。我们还评估了法案通过后继续晒黑的预测因素。结果。在参议院第41号法案通过之前,12%的学生报告在过去12个月里至少发生过一次室内晒黑事件。通过后,只有7%的学生报告在过去的12个月内室内晒黑(P < 0.0001)。继续室内晒黑的学生更有可能是老年人和女性,并从事其他危险行为,包括吸烟和饮酒。较低的父母教育水平也与持续晒黑有关。结论。室内晒黑限制对犹他州青少年的晒黑率有有益影响。更严格的限制可能会比允许父母放弃的限制产生更大的影响。需要加强禁令的执行力度,以进一步减少青少年获取毒品的机会。
{"title":"Decrease in Self-Reported Tanning Frequency among Utah Teens following the Passage of Utah Senate Bill 41: An Analysis of the Effects of Youth-Access Restriction Laws on Tanning Behaviors.","authors":"Rebecca G Simmons,&nbsp;Kristi Smith,&nbsp;Meghan Balough,&nbsp;Michael Friedrichs","doi":"10.1155/2014/839601","DOIUrl":"https://doi.org/10.1155/2014/839601","url":null,"abstract":"<p><p>Introduction. Adolescent use of indoor tanning facilities is associated with an increased risk in later development of melanoma skin cancers. States that have imposed age restrictions on access to indoor tanning generally show lower self-reported rates of indoor tanning than states with no restrictions, but currently no studies have assessed indoor tanning use before and after such restrictions. Methods. In 2013, we compared self-reported indoor tanning data collected in the Prevention Needs Assessment (PNA) survey in 2011 to PNA 2013 data. We also assessed predictors of continued tanning after passage of the bill. Results. Prior to the passage of Senate Bill 41, 12% of students reported at least one incident of indoor tanning in the past 12 months. After passage, only 7% of students reported indoor tanning in the past 12 months (P < 0.0001). Students who continued indoor tanning were more likely to be older and female and to engage in other risk behaviors, including smoking and alcohol use. Lower parental education levels were also associated with continued tanning. Conclusion. Indoor tanning restrictions showed beneficial impact on tanning rates in adolescents in Utah. Stricter restrictions may show even greater impact than restrictions that allow for parental waivers. Stronger enforcement of bans is needed to further reduce youth access. </p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2014 ","pages":"839601"},"PeriodicalIF":1.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/839601","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32662843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Sun Protection Beliefs among Hispanics in the US. 美国西班牙裔美国人的防晒信仰
IF 1.1 Q3 DERMATOLOGY Pub Date : 2014-01-01 Epub Date: 2014-11-09 DOI: 10.1155/2014/161960
Marimer Santiago-Rivas, Chang Wang, Lina Jandorf

Purpose. We reviewed the literature on sun protection beliefs in Hispanics living in the United States to explore what challenges are faced by area of research. Method. A review of PubMED, PsycINFO, and CINAHL databases was performed. Studies were published in peer-reviewed journals (in all years available) and written in English. The search terms used were ["skin cancer" OR "sun protection"] AND ["Latino" OR "Hispanic"] AND "beliefs." Eligible papers were included in the final analysis after meeting the following inclusion criteria: (1) the records had to quantitatively examine and report sun protection beliefs in Hispanics, (2) the number of Hispanic participants in the sample had to be clearly specified, and (3) studies reporting differences in sun protection beliefs between Hispanics and other racial and ethnic groups were included in the review. Results. Of the 92 articles identified, 11 met inclusion criteria and addressed sun protection beliefs regarding skin cancer seriousness and susceptibility, and benefits and barriers of sun protection and skin cancer risk behaviors. Characteristics of studies and results were examined. Conclusion. There is insufficient evidence to determine a pattern of sun protection beliefs among Hispanics in the United States. More quality studies are needed which focus on sun protection beliefs in Hispanics.

目的。我们回顾了居住在美国的西班牙裔美国人的防晒信仰方面的文献,以探索该研究领域面临的挑战。方法。对PubMED、PsycINFO和CINAHL数据库进行回顾。研究发表在同行评议的期刊上(在所有可用的年份),并以英文撰写。使用的搜索词是[“皮肤癌”或“防晒”]和[“拉丁裔”或“西班牙裔”]和“信仰”。符合以下纳入标准的论文被纳入最终分析:(1)记录必须定量检查和报告西班牙裔美国人的防晒信念,(2)样本中西班牙裔参与者的数量必须明确指定,(3)报告西班牙裔美国人与其他种族和族裔群体之间防晒信念差异的研究被纳入审查。结果。在确定的92篇文章中,有11篇符合纳入标准,并讨论了关于皮肤癌的严重性和易感性的防晒信念,以及防晒的益处和障碍以及皮肤癌风险行为。对研究的特点和结果进行了检查。结论。没有足够的证据来确定美国西班牙裔人的防晒信念模式。需要对西班牙裔人的防晒信念进行更多高质量的研究。
{"title":"Sun Protection Beliefs among Hispanics in the US.","authors":"Marimer Santiago-Rivas,&nbsp;Chang Wang,&nbsp;Lina Jandorf","doi":"10.1155/2014/161960","DOIUrl":"https://doi.org/10.1155/2014/161960","url":null,"abstract":"<p><p>Purpose. We reviewed the literature on sun protection beliefs in Hispanics living in the United States to explore what challenges are faced by area of research. Method. A review of PubMED, PsycINFO, and CINAHL databases was performed. Studies were published in peer-reviewed journals (in all years available) and written in English. The search terms used were [\"skin cancer\" OR \"sun protection\"] AND [\"Latino\" OR \"Hispanic\"] AND \"beliefs.\" Eligible papers were included in the final analysis after meeting the following inclusion criteria: (1) the records had to quantitatively examine and report sun protection beliefs in Hispanics, (2) the number of Hispanic participants in the sample had to be clearly specified, and (3) studies reporting differences in sun protection beliefs between Hispanics and other racial and ethnic groups were included in the review. Results. Of the 92 articles identified, 11 met inclusion criteria and addressed sun protection beliefs regarding skin cancer seriousness and susceptibility, and benefits and barriers of sun protection and skin cancer risk behaviors. Characteristics of studies and results were examined. Conclusion. There is insufficient evidence to determine a pattern of sun protection beliefs among Hispanics in the United States. More quality studies are needed which focus on sun protection beliefs in Hispanics. </p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2014 ","pages":"161960"},"PeriodicalIF":1.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/161960","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32844359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
The experience of melanoma follow-up care: an online survey of patients in australia. 黑素瘤随访护理的经验:澳大利亚患者的在线调查。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2014-01-01 Epub Date: 2014-11-19 DOI: 10.1155/2014/429149
Janine Mitchell, Peta Callaghan, Jackie Street, Susan Neuhaus, Taryn Bessen

Investigating patients' reports on the quality and consistency of melanoma follow-up care in Australia would assist in evaluating if this care is effective and meeting patients' needs. The objective of this study was to obtain and explore the patients' account of the technical and interpersonal aspects of melanoma follow-up care received. An online survey was conducted to acquire details of patients' experience. Participants were patients treated in Australia for primary melanoma. Qualitative and quantitative data about patient perceptions of the nature and quality of their follow-up care were collected, including provision of melanoma specific information, psychosocial support, and imaging tests received. Inconsistencies were reported in the provision and quality of care received. Patient satisfaction was generally low and provision of reassurance from health professionals was construed as an essential element of quality of care. "Gaps" in follow-up care for melanoma patients were identified, particularly provision of adequate psychosocial support and patient education. Focus on strategies for greater consistency in the provision of support, information, and investigations received, may generate a cost dividend which could be reinvested in preventive and supportive care and benefit patient well-being.

调查澳大利亚黑色素瘤随访治疗的质量和一致性的患者报告将有助于评估这种治疗是否有效并满足患者的需求。本研究的目的是获取和探讨患者对黑素瘤随访治疗的技术和人际关系方面的描述。进行了一项在线调查,以获取患者体验的细节。参与者是在澳大利亚接受原发性黑色素瘤治疗的患者。收集了关于患者对其后续护理性质和质量的看法的定性和定量数据,包括提供黑色素瘤特定信息、社会心理支持和接受的影像学检查。据报告,所接受的护理的提供和质量不一致。患者满意度普遍较低,保健专业人员提供的保证被视为护理质量的基本要素。确定了黑色素瘤患者随访护理的“差距”,特别是提供足够的社会心理支持和患者教育。注重在提供支持、信息和接受的调查方面更加一致的战略,可能会产生成本红利,可将其再投资于预防性和支持性护理,并有利于患者福祉。
{"title":"The experience of melanoma follow-up care: an online survey of patients in australia.","authors":"Janine Mitchell,&nbsp;Peta Callaghan,&nbsp;Jackie Street,&nbsp;Susan Neuhaus,&nbsp;Taryn Bessen","doi":"10.1155/2014/429149","DOIUrl":"https://doi.org/10.1155/2014/429149","url":null,"abstract":"<p><p>Investigating patients' reports on the quality and consistency of melanoma follow-up care in Australia would assist in evaluating if this care is effective and meeting patients' needs. The objective of this study was to obtain and explore the patients' account of the technical and interpersonal aspects of melanoma follow-up care received. An online survey was conducted to acquire details of patients' experience. Participants were patients treated in Australia for primary melanoma. Qualitative and quantitative data about patient perceptions of the nature and quality of their follow-up care were collected, including provision of melanoma specific information, psychosocial support, and imaging tests received. Inconsistencies were reported in the provision and quality of care received. Patient satisfaction was generally low and provision of reassurance from health professionals was construed as an essential element of quality of care. \"Gaps\" in follow-up care for melanoma patients were identified, particularly provision of adequate psychosocial support and patient education. Focus on strategies for greater consistency in the provision of support, information, and investigations received, may generate a cost dividend which could be reinvested in preventive and supportive care and benefit patient well-being. </p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2014 ","pages":"429149"},"PeriodicalIF":1.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/429149","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32931667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Saphenous vein sparing superficial inguinal dissection in lower extremity melanoma. 保留隐静脉的下肢黑色素瘤腹股沟浅夹层。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2014-01-01 Epub Date: 2014-07-13 DOI: 10.1155/2014/652123
Muhammed Beşir Oztürk, Arzu Akan, Ozay Ozkaya, Onur Egemen, Ali Rıza Oreroğlu, Turgut Kayadibi, Mithat Akan

Aim. The classic inguinal lymph node dissection is the main step for the regional control of the lower extremity melanoma, but this surgical procedure is associated with significant postoperative morbidity. The permanent lymphedema is the most devastating long-term complication leading to a significant decrease in the patient's quality of life. In this study we present our experience with modified, saphenous vein sparing, inguinal lymph node dissections for patients with melanoma of the lower extremity. Methods. Twenty one patients (10 women, 11 men) who underwent saphenous vein sparing superficial inguinal lymph node dissection for the melanoma of lower extremity were included in this study. The effects of saphenous vein sparing on postoperative complications were evaluated. Results. We have observed the decreased rate of long-term lymphedema in patients undergoing inguinal lymphadenectomy for the lower extremity melanoma. Conclusion. The inguinal lymphadenectomy with saphenous vein preservation in lower extremity melanoma patients seems to be an oncologically safe procedure and it may offer reduced long-term morbidity.

的目标。经典的腹股沟淋巴结清扫术是局部控制下肢黑色素瘤的主要步骤,但该手术过程与显著的术后发病率相关。永久性淋巴水肿是导致患者生活质量显著下降的最具破坏性的长期并发症。在这项研究中,我们介绍了我们的经验改良,隐静脉保留,腹股沟淋巴结清扫患者的黑色素瘤的下肢。方法。本研究包括21例(10名女性,11名男性)因下肢黑色素瘤行保留隐静脉的腹股沟浅淋巴结清扫术。观察保留隐静脉对术后并发症的影响。结果。我们观察到长期淋巴水肿率下降的患者接受腹股沟淋巴结切除术为下肢黑色素瘤。结论。保留隐静脉的腹股沟淋巴结切除术在下肢黑色素瘤患者中似乎是一种肿瘤学上安全的手术,它可以降低长期发病率。
{"title":"Saphenous vein sparing superficial inguinal dissection in lower extremity melanoma.","authors":"Muhammed Beşir Oztürk,&nbsp;Arzu Akan,&nbsp;Ozay Ozkaya,&nbsp;Onur Egemen,&nbsp;Ali Rıza Oreroğlu,&nbsp;Turgut Kayadibi,&nbsp;Mithat Akan","doi":"10.1155/2014/652123","DOIUrl":"https://doi.org/10.1155/2014/652123","url":null,"abstract":"<p><p>Aim. The classic inguinal lymph node dissection is the main step for the regional control of the lower extremity melanoma, but this surgical procedure is associated with significant postoperative morbidity. The permanent lymphedema is the most devastating long-term complication leading to a significant decrease in the patient's quality of life. In this study we present our experience with modified, saphenous vein sparing, inguinal lymph node dissections for patients with melanoma of the lower extremity. Methods. Twenty one patients (10 women, 11 men) who underwent saphenous vein sparing superficial inguinal lymph node dissection for the melanoma of lower extremity were included in this study. The effects of saphenous vein sparing on postoperative complications were evaluated. Results. We have observed the decreased rate of long-term lymphedema in patients undergoing inguinal lymphadenectomy for the lower extremity melanoma. Conclusion. The inguinal lymphadenectomy with saphenous vein preservation in lower extremity melanoma patients seems to be an oncologically safe procedure and it may offer reduced long-term morbidity. </p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2014 ","pages":"652123"},"PeriodicalIF":1.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/652123","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32587967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
A clinicopathological and immunohistochemical correlation in cutaneous metastases from internal malignancies: a five-year study. 内部恶性肿瘤皮肤转移的临床病理和免疫组织化学相关性:一项为期五年的研究。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2014-01-01 Epub Date: 2014-08-25 DOI: 10.1155/2014/793937
Sarita Nibhoria, Kanwardeep Kaur Tiwana, Manmeet Kaur, Sumir Kumar
Cutaneous metastases from internal malignancies are uncommon and occur in 0.6%–10.4% of all patients with cancer. In most cases, cutaneous metastases develop after the initial diagnosis of the primary internal malignancy and late in the course of the disease. Skin tumors are infrequent in Asian population and cutaneous metastases are quite rare. Cutaneous metastases carry a poor prognosis with average survival of few months. In the present five-year study 1924 malignant tumors were screened which included only nine cases of cutaneous metastatic deposits. A wide range of site and clinical presentations including nodules, plaques, and ulcers was noted. Histopathological findings were significant and corresponded with the primary internal malignancy. Cutaneous metastases from breast carcinoma (44.4%) were the most common finding followed by non-Hodgkin lymphoma and renal cell carcinoma (22.2% each) and carcinoma cervix (11.1%). The aim of our study is to classify the cutaneous metastases and to evaluate their clinicopathologic and immunohistochemical correlation with the primary tumor.
内部恶性肿瘤的皮肤转移并不常见,发生率为所有癌症患者的0.6%-10.4%。在大多数病例中,皮肤转移发生在原发性内部恶性肿瘤的初步诊断之后和病程晚期。皮肤肿瘤在亚洲人群中并不常见,皮肤转移也相当罕见。皮肤转移的预后较差,平均生存期只有几个月。在目前为期五年的研究中,共筛查了1924例恶性肿瘤,其中只有9例皮肤转移性沉积。广泛的部位和临床表现包括结节、斑块和溃疡。组织病理学结果显著,符合原发性内部恶性肿瘤。最常见的是乳腺癌的皮肤转移(44.4%),其次是非霍奇金淋巴瘤和肾细胞癌(各22.2%)和子宫颈癌(11.1%)。我们研究的目的是对皮肤转移进行分类,并评估其与原发肿瘤的临床病理和免疫组织化学相关性。
{"title":"A clinicopathological and immunohistochemical correlation in cutaneous metastases from internal malignancies: a five-year study.","authors":"Sarita Nibhoria,&nbsp;Kanwardeep Kaur Tiwana,&nbsp;Manmeet Kaur,&nbsp;Sumir Kumar","doi":"10.1155/2014/793937","DOIUrl":"https://doi.org/10.1155/2014/793937","url":null,"abstract":"Cutaneous metastases from internal malignancies are uncommon and occur in 0.6%–10.4% of all patients with cancer. In most cases, cutaneous metastases develop after the initial diagnosis of the primary internal malignancy and late in the course of the disease. Skin tumors are infrequent in Asian population and cutaneous metastases are quite rare. Cutaneous metastases carry a poor prognosis with average survival of few months. In the present five-year study 1924 malignant tumors were screened which included only nine cases of cutaneous metastatic deposits. A wide range of site and clinical presentations including nodules, plaques, and ulcers was noted. Histopathological findings were significant and corresponded with the primary internal malignancy. Cutaneous metastases from breast carcinoma (44.4%) were the most common finding followed by non-Hodgkin lymphoma and renal cell carcinoma (22.2% each) and carcinoma cervix (11.1%). The aim of our study is to classify the cutaneous metastases and to evaluate their clinicopathologic and immunohistochemical correlation with the primary tumor.","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2014 ","pages":"793937"},"PeriodicalIF":1.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/793937","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32662842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Gene expression differences predict treatment outcome of merkel cell carcinoma patients. 基因表达差异预测默克尔细胞癌患者的治疗结果。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2014-01-01 Epub Date: 2014-01-30 DOI: 10.1155/2014/596459
Loren Masterson, Bryan J Thibodeau, Laura E Fortier, Timothy J Geddes, Barbara L Pruetz, Rajwant Malhotra, Richard Keidan, George D Wilson

Due to the rarity of Merkel cell carcinoma (MCC), prospective clinical trials have not been practical. This study aimed to identify biomarkers with prognostic significance. While sixty-two patients were identified who were treated for MCC at our institution, only seventeen patients had adequate formalin-fixed paraffin-embedded archival tissue and followup to be included in the study. Patients were stratified into good, moderate, or poor prognosis. Laser capture microdissection was used to isolate tumor cells for subsequent RNA isolation and gene expression analysis with Affymetrix GeneChip Human Exon 1.0 ST arrays. Among the 191 genes demonstrating significant differential expression between prognostic groups, keratin 20 and neurofilament protein have previously been identified in studies of MCC and were significantly upregulated in tumors from patients with a poor prognosis. Immunohistochemistry further established that keratin 20 was overexpressed in the poor prognosis tumors. In addition, novel genes of interest such as phospholipase A2 group X, kinesin family member 3A, tumor protein D52, mucin 1, and KIT were upregulated in specimens from patients with poor prognosis. Our pilot study identified several gene expression differences which could be used in the future as prognostic biomarkers in MCC patients.

由于默克尔细胞癌(MCC)的罕见性,前瞻性临床试验尚未实现。本研究旨在确定具有预后意义的生物标志物。在我们的机构中,有62名患者接受了MCC的治疗,但只有17名患者有足够的福尔马林固定石蜡包埋档案组织和随访被纳入研究。患者被分为良好、中度和不良预后。采用激光捕获显微解剖分离肿瘤细胞,随后用Affymetrix GeneChip Human Exon 1.0 ST阵列进行RNA分离和基因表达分析。在预后组之间表现出显著差异表达的191个基因中,角蛋白20和神经丝蛋白先前已在MCC研究中被发现,并且在预后不良患者的肿瘤中显著上调。免疫组化进一步证实角蛋白20在预后不良肿瘤中过表达。此外,新的相关基因如磷脂酶A2组X、激酶家族成员3A、肿瘤蛋白D52、粘蛋白1和KIT在预后不良患者的标本中上调。我们的初步研究确定了几个基因表达差异,这些差异可以在未来用作MCC患者的预后生物标志物。
{"title":"Gene expression differences predict treatment outcome of merkel cell carcinoma patients.","authors":"Loren Masterson,&nbsp;Bryan J Thibodeau,&nbsp;Laura E Fortier,&nbsp;Timothy J Geddes,&nbsp;Barbara L Pruetz,&nbsp;Rajwant Malhotra,&nbsp;Richard Keidan,&nbsp;George D Wilson","doi":"10.1155/2014/596459","DOIUrl":"https://doi.org/10.1155/2014/596459","url":null,"abstract":"<p><p>Due to the rarity of Merkel cell carcinoma (MCC), prospective clinical trials have not been practical. This study aimed to identify biomarkers with prognostic significance. While sixty-two patients were identified who were treated for MCC at our institution, only seventeen patients had adequate formalin-fixed paraffin-embedded archival tissue and followup to be included in the study. Patients were stratified into good, moderate, or poor prognosis. Laser capture microdissection was used to isolate tumor cells for subsequent RNA isolation and gene expression analysis with Affymetrix GeneChip Human Exon 1.0 ST arrays. Among the 191 genes demonstrating significant differential expression between prognostic groups, keratin 20 and neurofilament protein have previously been identified in studies of MCC and were significantly upregulated in tumors from patients with a poor prognosis. Immunohistochemistry further established that keratin 20 was overexpressed in the poor prognosis tumors. In addition, novel genes of interest such as phospholipase A2 group X, kinesin family member 3A, tumor protein D52, mucin 1, and KIT were upregulated in specimens from patients with poor prognosis. Our pilot study identified several gene expression differences which could be used in the future as prognostic biomarkers in MCC patients. </p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2014 ","pages":"596459"},"PeriodicalIF":1.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/596459","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32179811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
The pink rim sign: location of pink as an indicator of melanoma in dermoscopic images. 粉红色边缘标志:在皮肤镜图像中,粉红色作为黑色素瘤的指示。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2014-01-01 Epub Date: 2014-02-03 DOI: 10.1155/2014/719740
Ryan K Rader, Katie S Payne, Uday Guntupalli, Harold S Rabinovitz, Maggie C Oliviero, Rhett J Drugge, Joseph J Malters, William V Stoecker

Background. In dermoscopic images, multiple shades of pink have been described in melanoma without specifying location of these areas within the lesion. Objective. The purpose of this study was to determine the statistics for the presence of centrally and peripherally located pink melanoma and benign melanocytic lesions. Methods. Three observers, untrained in dermoscopy, each retrospectively analyzed 1290 dermoscopic images (296 melanomas (170 in situ and 126 invasive), 994 benign melanocytic nevi) and assessed the presence of any shade of pink in the center and periphery of the lesion. Results. Pink was located in the peripheral region in 14.5% of melanomas and 6.3% of benign melanocytic lesions, yielding an odds ratio of 2.51 (95% CI: 1.7-3.8, P < 0.0001). Central pink was located in 12.8% of melanomas and 21.8% of benign lesions, yielding an odds ratio of 0.462 (95% CI: 0.67, P = 0.204). Pink in melanoma in situ tended to be present throughout the lesion (68% of pink lesions). Pink in invasive melanoma was present in 17% of cases, often presenting as a pink rim. Conclusions. The presence of pink in the periphery or rim of a dermoscopic melanocytic lesion image provides an indication of malignancy. We offer the "pink rim sign" as a clue to the dermoscopic diagnosis of invasive melanoma.

背景。在皮肤镜图像中,在黑色素瘤中描述了多种色调的粉红色,但没有指明这些区域在病变中的位置。目标。本研究的目的是确定位于中心和周围的粉红色黑色素瘤和良性黑色素细胞病变的统计数据。方法。三名未接受过皮肤镜检查训练的观察者,每人回顾性分析1290张皮肤镜图像(296张黑色素瘤(170张原位,126张浸润性),994张良性黑素细胞痣),并评估病变中心和周围是否存在任何粉红色阴影。结果。在14.5%的黑素瘤和6.3%的良性黑素细胞病变中,粉红色位于外周区域,优势比为2.51 (95% CI: 1.7-3.8, P < 0.0001)。中心粉红色位于12.8%的黑色素瘤和21.8%的良性病变,优势比为0.462 (95% CI: 0.67, P = 0.204)。原位黑色素瘤的粉红色倾向于出现在整个病变中(68%的粉红色病变)。侵袭性黑色素瘤的粉红色出现在17%的病例中,通常表现为粉红色的边缘。结论。皮肤镜下黑素细胞病变图像的外围或边缘出现粉红色提示恶性肿瘤。我们提供“粉红边缘征”作为皮肤镜诊断侵袭性黑色素瘤的线索。
{"title":"The pink rim sign: location of pink as an indicator of melanoma in dermoscopic images.","authors":"Ryan K Rader,&nbsp;Katie S Payne,&nbsp;Uday Guntupalli,&nbsp;Harold S Rabinovitz,&nbsp;Maggie C Oliviero,&nbsp;Rhett J Drugge,&nbsp;Joseph J Malters,&nbsp;William V Stoecker","doi":"10.1155/2014/719740","DOIUrl":"https://doi.org/10.1155/2014/719740","url":null,"abstract":"<p><p>Background. In dermoscopic images, multiple shades of pink have been described in melanoma without specifying location of these areas within the lesion. Objective. The purpose of this study was to determine the statistics for the presence of centrally and peripherally located pink melanoma and benign melanocytic lesions. Methods. Three observers, untrained in dermoscopy, each retrospectively analyzed 1290 dermoscopic images (296 melanomas (170 in situ and 126 invasive), 994 benign melanocytic nevi) and assessed the presence of any shade of pink in the center and periphery of the lesion. Results. Pink was located in the peripheral region in 14.5% of melanomas and 6.3% of benign melanocytic lesions, yielding an odds ratio of 2.51 (95% CI: 1.7-3.8, P < 0.0001). Central pink was located in 12.8% of melanomas and 21.8% of benign lesions, yielding an odds ratio of 0.462 (95% CI: 0.67, P = 0.204). Pink in melanoma in situ tended to be present throughout the lesion (68% of pink lesions). Pink in invasive melanoma was present in 17% of cases, often presenting as a pink rim. Conclusions. The presence of pink in the periphery or rim of a dermoscopic melanocytic lesion image provides an indication of malignancy. We offer the \"pink rim sign\" as a clue to the dermoscopic diagnosis of invasive melanoma. </p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2014 ","pages":"719740"},"PeriodicalIF":1.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/719740","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32184641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Validity and stability of the decisional balance for sun protection inventory. 防晒产品库存决策平衡的有效性和稳定性。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2014-01-01 Epub Date: 2014-12-07 DOI: 10.1155/2014/190541
Hui-Qing Yin, Joseph S Rossi, Colleen A Redding, Andrea L Paiva, Steven F Babbin, Wayne F Velicer

The 8-item Decisional Balance for sun protection inventory (SunDB) assesses the relative importance of the perceived advantages (Pros) and disadvantages (Cons) of sun protective behaviors. This study examined the psychometric properties of the SunDB measure, including invariance of the measurement model, in a population-based sample of N = 1336 adults. Confirmatory factor analyses supported the theoretically based 2-factor (Pros, Cons) model, with high internal consistencies for each subscale (α ≥ .70). Multiple-sample CFA established that this factor pattern was invariant across multiple population subgroups, including gender, racial identity, age, education level, and stage of change subgroups. Multivariate analysis by stage of change replicated expected patterns for SunDB (Pros η (2) = .15, Cons η (2) = .02). These results demonstrate the internal and external validity and measurement stability of the SunDB instrument in adults, supporting its use in research and intervention.

防晒清单(SunDB)的8项决策平衡评估了防晒行为的感知优势(优点)和劣势(缺点)的相对重要性。本研究在以人口为基础的N = 1336名成年人样本中检验了SunDB测量的心理测量特性,包括测量模型的不变性。验证性因子分析支持基于理论的2因子(赞成,反对)模型,每个子量表具有较高的内部一致性(α≥0.70)。多样本CFA证实,该因素模式在包括性别、种族认同、年龄、教育水平和变化阶段在内的多个人口亚组中是不变的。变化阶段的多变量分析复制了SunDB的预期模式(赞成η(2) = .15,反对η(2) = .02)。这些结果证明了sunb仪器在成人中的内部和外部有效性和测量稳定性,支持其在研究和干预中的应用。
{"title":"Validity and stability of the decisional balance for sun protection inventory.","authors":"Hui-Qing Yin,&nbsp;Joseph S Rossi,&nbsp;Colleen A Redding,&nbsp;Andrea L Paiva,&nbsp;Steven F Babbin,&nbsp;Wayne F Velicer","doi":"10.1155/2014/190541","DOIUrl":"https://doi.org/10.1155/2014/190541","url":null,"abstract":"<p><p>The 8-item Decisional Balance for sun protection inventory (SunDB) assesses the relative importance of the perceived advantages (Pros) and disadvantages (Cons) of sun protective behaviors. This study examined the psychometric properties of the SunDB measure, including invariance of the measurement model, in a population-based sample of N = 1336 adults. Confirmatory factor analyses supported the theoretically based 2-factor (Pros, Cons) model, with high internal consistencies for each subscale (α ≥ .70). Multiple-sample CFA established that this factor pattern was invariant across multiple population subgroups, including gender, racial identity, age, education level, and stage of change subgroups. Multivariate analysis by stage of change replicated expected patterns for SunDB (Pros η (2) = .15, Cons η (2) = .02). These results demonstrate the internal and external validity and measurement stability of the SunDB instrument in adults, supporting its use in research and intervention. </p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2014 ","pages":"190541"},"PeriodicalIF":1.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/190541","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32940780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Melanoma Development and Progression Are Associated with Rad6 Upregulation and β -Catenin Relocation to the Cell Membrane. 黑色素瘤的发生和发展与Rad6上调和β -Catenin迁移到细胞膜有关。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2014-01-01 Epub Date: 2014-05-06 DOI: 10.1155/2014/439205
Karli Rosner, Darius R Mehregan, Evangelia Kirou, Judith Abrams, Seongho Kim, Michelle Campbell, Jillian Frieder, Kelsey Lawrence, Brittany Haynes, Malathy P V Shekhar

We have previously demonstrated that Rad6 and β -catenin enhance each other's expression through a positive feedback loop to promote breast cancer development/progression. While β -catenin has been implicated in melanoma pathogenesis, Rad6 function has not been investigated. Here, we examined the relationship between Rad6 and β -catenin in melanoma development and progression. Eighty-eight cutaneous tumors, 30 nevi, 29 primary melanoma, and 29 metastatic melanomas, were immunostained with anti- β -catenin and anti-Rad6 antibodies. Strong expression of Rad6 was observed in only 27% of nevi as compared to 100% of primary and 96% of metastatic melanomas. β -Catenin was strongly expressed in 97% of primary and 93% of metastatic melanomas, and unlike Rad6, in 93% of nevi. None of the tumors expressed nuclear β -catenin. β -Catenin was exclusively localized on the cell membrane of 55% of primary, 62% of metastatic melanomas, and only 10% of nevi. Cytoplasmic β -catenin was detected in 90% of nevi, 17% of primary, and 8% of metastatic melanoma, whereas 28% of primary and 30% of metastatic melanomas exhibited β -catenin at both locations. These data suggest that melanoma development and progression are associated with Rad6 upregulation and membranous redistribution of β -catenin and that β -catenin and Rad6 play independent roles in melanoma development.

我们之前已经证明,Rad6和β -catenin通过正反馈回路增强彼此的表达,促进乳腺癌的发生/进展。虽然β -catenin与黑色素瘤的发病有关,但Rad6的功能尚未被研究。在这里,我们研究了Rad6和β -catenin在黑色素瘤发生和发展中的关系。88个皮肤肿瘤,30个痣,29个原发性黑色素瘤和29个转移性黑色素瘤,用抗β -catenin和抗rad6抗体进行免疫染色。与100%的原发性黑色素瘤和96%的转移性黑色素瘤相比,在27%的痣中观察到Rad6的强表达。β -Catenin在97%的原发黑色素瘤和93%的转移性黑色素瘤中强烈表达,与Rad6不同,在93%的痣中强烈表达。所有肿瘤均未表达核β -连环蛋白。β -Catenin仅局限于55%的原发性黑色素瘤、62%的转移性黑色素瘤和10%的痣的细胞膜上。细胞质β -catenin在90%的痣、17%的原发和8%的转移性黑色素瘤中检测到,而28%的原发黑色素瘤和30%的转移性黑色素瘤在两个部位均表现出β -catenin。这些数据表明黑色素瘤的发生和发展与Rad6上调和β -catenin的膜重分布有关,β -catenin和Rad6在黑色素瘤的发展中发挥独立的作用。
{"title":"Melanoma Development and Progression Are Associated with Rad6 Upregulation and β -Catenin Relocation to the Cell Membrane.","authors":"Karli Rosner,&nbsp;Darius R Mehregan,&nbsp;Evangelia Kirou,&nbsp;Judith Abrams,&nbsp;Seongho Kim,&nbsp;Michelle Campbell,&nbsp;Jillian Frieder,&nbsp;Kelsey Lawrence,&nbsp;Brittany Haynes,&nbsp;Malathy P V Shekhar","doi":"10.1155/2014/439205","DOIUrl":"https://doi.org/10.1155/2014/439205","url":null,"abstract":"<p><p>We have previously demonstrated that Rad6 and β -catenin enhance each other's expression through a positive feedback loop to promote breast cancer development/progression. While β -catenin has been implicated in melanoma pathogenesis, Rad6 function has not been investigated. Here, we examined the relationship between Rad6 and β -catenin in melanoma development and progression. Eighty-eight cutaneous tumors, 30 nevi, 29 primary melanoma, and 29 metastatic melanomas, were immunostained with anti- β -catenin and anti-Rad6 antibodies. Strong expression of Rad6 was observed in only 27% of nevi as compared to 100% of primary and 96% of metastatic melanomas. β -Catenin was strongly expressed in 97% of primary and 93% of metastatic melanomas, and unlike Rad6, in 93% of nevi. None of the tumors expressed nuclear β -catenin. β -Catenin was exclusively localized on the cell membrane of 55% of primary, 62% of metastatic melanomas, and only 10% of nevi. Cytoplasmic β -catenin was detected in 90% of nevi, 17% of primary, and 8% of metastatic melanoma, whereas 28% of primary and 30% of metastatic melanomas exhibited β -catenin at both locations. These data suggest that melanoma development and progression are associated with Rad6 upregulation and membranous redistribution of β -catenin and that β -catenin and Rad6 play independent roles in melanoma development. </p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2014 ","pages":"439205"},"PeriodicalIF":1.1,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/439205","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32394086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
期刊
Journal of Skin Cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1